
Dr. Susan M. Domchek is a leading breast cancer researcher who focuses on understanding inherited cancer risks, improving treatment, and finding ways to prevent cancer before it develops. Her work has helped advance treatments for people with BRCA gene changes and offers hope to families who may face a higher risk of cancer.
Her research reminds us that understanding our family health history can be an important step toward protecting ourselves and future generations.

Dr. Carey is an internationally recognized breast cancer physician-researcher and Distinguished Professor for Breast Cancer Research at UNC. She directs UNC Lineberger's Center for Triple-Negative Breast Cancer, and her research includes breast cancer subtypes, metastatic breast cancer and developing more effective treatments. UNC Lineberger Cancer Center

Dr. Abou-Alfa is a medical oncologist specializing in primary liver cancer (hepatocellular carcinoma) and other hepatobiliary cancers. His research has focused on improving cancer therapies, including treatments for difficult-to-treat gastrointestinal cancers.

Dr. Singal is Chief of Hepatology and Director of the Liver Tumor Program at UT Southwestern. A major focus of his research is finding and treating liver cancer while curative treatment may still be possible. He has also been a lead author of U.S. liver cancer guidelines. In August 2026, UT Southwestern reported that he co-led development of new consensus-based liver cancer treatment recommendations incorporating recent advances in care.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.